GAMMA Investing LLC Buys 1,762 Shares of CME Group Inc. $CME

GAMMA Investing LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 21.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,974 shares of the financial services provider’s stock after purchasing an additional 1,762 shares during the period. GAMMA Investing LLC’s holdings in CME Group were worth $2,724,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. Amundi grew its holdings in CME Group by 24.0% during the second quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after purchasing an additional 385,225 shares during the period. Truist Financial Corp increased its stake in CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after purchasing an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC raised its holdings in CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC raised its holdings in CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after purchasing an additional 3,919 shares during the period. Finally, Victory Financial Group LLC boosted its position in shares of CME Group by 310.2% during the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after purchasing an additional 2,302 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Goldman Sachs published a bullish forecast for CME, calling for strong price appreciation — this likely supported upside sentiment among investors. Goldman Sachs Forecasts Strong Price Appreciation for CME Group
• Neutral Sentiment: Analyst coverage remains mixed but constructive overall: multiple firms maintain buy/overweight stances and some price targets (e.g., TD Cowen, Morgan Stanley) are above the current trading level, while others (e.g., JP Morgan) are more conservative — this creates a balanced catalyst set for price discovery. Quiver Quant – Analyst ratings & price targets summary
• Neutral Sentiment: Reported short-interest data for March shows zero shares shorted (days-to-cover 0.0), but the figures look erroneous/artefactual (NaN and repeated 0 values). As reported, this offers no reliable signal on bearish positioning.
• Negative Sentiment: Insider selling: CME’s Senior MD & General Counsel Jonathan L. Marcus sold 3,291 shares (~$1.1M) on March 17, reducing his stake by ~31%. Market participants often view sizable insider sales as a short-term negative signal. SEC Form 4 – Marcus sale
• Negative Sentiment: Aggregated insider activity over recent months shows more sales than buys (multiple senior executives have sold shares), which can weigh on sentiment if investors interpret this as executives taking gains rather than signaling long-term conviction. Quiver Quant – Insider activity

CME Group Trading Up 0.6%

CME opened at $310.71 on Friday. The stock has a market capitalization of $112.04 billion, a P/E ratio of 27.84, a P/E/G ratio of 3.34 and a beta of 0.24. CME Group Inc. has a 12 month low of $248.53 and a 12 month high of $329.16. The firm’s fifty day simple moving average is $299.19 and its 200 day simple moving average is $280.13. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the company earned $2.52 EPS. The company’s revenue was up 8.1% on a year-over-year basis. As a group, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is currently 46.59%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CME shares. The Goldman Sachs Group boosted their price target on shares of CME Group from $266.00 to $275.00 and gave the company a “sell” rating in a report on Monday. Barclays lifted their target price on CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Royal Bank Of Canada boosted their target price on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Finally, Morgan Stanley raised their price target on CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $304.06.

Insider Buying and Selling at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director owned 43,007 shares in the company, valued at $13,317,117.55. The trade was a 8.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 8,539 shares of company stock valued at $2,713,821 in the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.